Canadian researchers at institutions like McGill University are reportedly developing a spray-based COVID-19 vaccine delivered via a device in the mouth. This delivery method contrasts with the original mRNA vaccines designed for deltoid injection to isolate spike protein production. Skepticism remains regarding the efficacy of inhaled spike proteins compared to traditional intramuscular shots.


